Related Experiment Video
Updated: Jul 19, 2026
02:47
Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System
Published on: May 12, 2023
[Cardiovascular diseases and gene polymorphisms]
L Bartosová1, V Strnadová, M Bartos
1Ustav humánni farmakologie a toxikologie Farmaceutická fakulta VFU, Brno. bartosoval@vfu.cz
Casopis Lekaru Ceskych
|November 10, 2006
Summary
Genetic factors significantly contribute to cardiovascular diseases in the Czech Republic, alongside lifestyle. This review examines gene polymorphisms and mutations linked to heart failure, hypertension, and arrhythmias.
Area of Science:
- Genetics and Cardiovascular Medicine
Context:
- Cardiovascular diseases are a leading cause of mortality in the Czech Republic.
- Both lifestyle factors and hereditary predisposition play crucial roles in disease development.
Purpose:
- To review gene polymorphisms and mutations associated with cardiovascular diseases.
- To summarize findings on genetic associations with heart failure, hypertension, and arrhythmias.
Summary:
- Discusses specific gene polymorphisms, including those in beta-adrenergic signaling, angiotensin system genes, ACE gene, and angiotensin II receptor gene.
- Highlights research from the Czech Republic and worldwide on genetic links to cardiovascular pathology.
- Includes a table summarizing key data on gene polymorphism associations.
Impact:
- Provides an overview of the genetic underpinnings of common cardiovascular conditions.
- Informs understanding of hereditary predispositions in cardiovascular disease management.
- Aids researchers and clinicians in identifying genetic risk factors.
Related Concept Videos
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:27Pharmacogenetics of Drug Metabolism: Overview
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
01:27Psychoneuroimmunology: Cardiovascular Disease
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
A key area of focus in PNI is the relationship between stress and coronary...
01:11Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...